Jun 23, 2025 · Glucagon-like peptide-1 (GLP-1) receptor agonists are a well-established treatment option for obesity and type 2 diabetes. However, there is a growing need for additional options to …

Oct 17, 2024 · Groundbreaking research presented at UEG Week 2024 introduces a promising new treatment approach for type 2 diabetes (T2D) that has the potential to greatly reduce or even …

Apr 11, 2025 · From expanding treatment options to groundbreaking research, progress is happening. With each breakthrough, we move closer to better care, improved quality of life and—one day—a cure.

Aug 1, 2025 · Over the past decade or so there has been a daunting increase in the number and pharmacologic breadth of medications available to treat patients with diabetes mellitus. There are …

Mar 18, 2025 · From promising research to clinical-stage cell therapies and AI software updates, diabetes treatment and management is poised to change like never before.

1 day ago · New era of health: How GLP-1 drugs are revolutionising obesity and diabetes treatment Obesity and diabetes treatment is undergoing a revolution with the advent of GLP-1 drugs, which …

Millions of people have type 2 diabetes, and many carry out the daily routine of medication, blood sugar checks, and constant monitoring. News from a Las Vegas study has started to spark steady ...

May 15, 2025 · Type 2 diabetes treatment has evolved dramatically in recent years—and 2025 is no exception. With new therapies, digital tools, and updated care models, the way clinicians approach …

Jun 1, 2025 · The treatment of Type 2 diabetes is undergoing rapid transformation, with 2025 bringing promising new solutions for millions of patients. Breakthroughs in pharmaceuticals, digital health …

6 days ago · Building on the clinical success of first-generation SGLT2 inhibitors, such as empagliflozin and dapagliflozin, next-generation SGLT2-based therapies have been developed with the aim of …